Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray

British Journal of Cancer
Y HedbergG Landberg

Abstract

Aberrations in the G1/S transition of the cell cycle have been observed in many malignancies and seem to be critical in the transformation process. Few studies have delineated the presence of G1/S regulatory defects and their clinical relevance in renal cell carcinoma (RCC). Therefore, we have examined the protein contents of cyclin D1, D3, E, and p27 in 218 RCCs, using tissue microarray and immunohistochemistry. The results from a subset of tumours were confirmed by Western blotting and immunohistochemical staining of regular tissue sections. Interestingly, low protein contents of cyclin D1 and p27 were associated with high nuclear grade, large tumour size, and poor prognosis for patients with conventional tumours. We further observed substantial differences in the pattern of G1/S regulatory defects between the different RCC subtypes. The majority of both conventional and papillary cases expressed p27; however, chromophobe tumours generally lacked p27 staining. In addition, conventional RCCs often expressed high cyclin D1 protein levels, while papillary RCCs exhibited high cyclin E. In summary, we have shown that G1/S regulatory defects are present in RCC and are associated with clinico-pathological parameters. The pattern of ...Continue Reading

References

Jan 26, 1996·International Journal of Cancer. Journal International Du Cancer·J BartkovaJ Bartek
Dec 1, 1995·Current Opinion in Cell Biology·E Lees
Apr 22, 1996·International Journal of Cancer. Journal International Du Cancer·C GillettD Barnes
Dec 1, 1996·Scandinavian Journal of Urology and Nephrology·P LarssonB Ljungberg
Dec 9, 1997·The Journal of Pathology·G KovacsB Zbar
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Apr 30, 1999·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·N H NielsenG Landberg
Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·Y HedbergG Landberg
Aug 10, 1999·Nature·W C HahnR A Weinberg
Apr 27, 2000·Nature Cell Biology·J W Harbour, D C Dean
Jan 5, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·R L CampD L Rimm
Mar 21, 2001·Human Molecular Genetics·O P KallioniemiG Sauter
Mar 29, 2002·The Journal of Pathology·Judith A McKayGraeme I Murray
Aug 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C-F HwangH-W Chang
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Ylva HedbergGöran Landberg

❮ Previous
Next ❯

Citations

Dec 15, 2007·The Journal of Clinical Investigation·Jonas SjölundHåkan Axelson
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinhee KimCheryl Lyn Walker
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·George J Netto, Liang Cheng
Aug 6, 2008·International Urology and Nephrology·Ambrosi PertiaArchil Chkhotua
Oct 21, 2011·Expert Opinion on Investigational Drugs·Bruno VincenziGiuseppe Tonini
Sep 24, 2015·Molecular Medicine Reports·Yonggen ZouDianming Jiang
Mar 16, 2006·BJU International·Johanna SandlundTorgny Rasmuson
Oct 17, 2008·Journal of Experimental & Clinical Cancer Research : CR·Zheng LiuKejia Ding
Jun 5, 2004·Der Urologe. Ausg. A·Börje Ljungberg
Feb 28, 2009·Pathology, Research and Practice·H BarrocaJ Müller-Höcker
Oct 13, 2007·Critical Reviews in Oncology/hematology·John S LamRobert A Figlin
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Ylva HedbergGöran Landberg
Apr 6, 2006·Nature Clinical Practice. Oncology·Olivier RouvièreDenis Lyonnet
Nov 6, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tao ShiSteve Horvath
Aug 10, 2006·World Journal of Urology·A S MerseburgerM A Kuczyk
Apr 23, 2009·International Journal of Cancer. Journal International Du Cancer·Raviprakash T SitaramGöran Roos
Dec 25, 2007·Advances in Anatomic Pathology·Andrew N YoungMahul B Amin
Jun 22, 2010·Targeted Oncology·Hamdy AzimBernard Escudier
Apr 20, 2005·Oncogene·Amit DeshpandePhilip W Hinds
Oct 18, 2014·Journal of Hematology & Oncology·Qian ChuKongming Wu
Mar 8, 2006·Japanese Journal of Clinical Oncology·Piotr PotemskiRadzislaw Kordek
Feb 21, 2007·International Urology and Nephrology·Ambrosi PertiaArchil Chkhotua
Jun 27, 2012·Oncogene·K ShanmugasundaramS Sudarshan
Nov 19, 2013·International Urology and Nephrology·M S LimaG E Barros-Silva
Apr 8, 2004·Current Opinion in Oncology·W Kimryn Rathmell, Paul A Godley
Aug 3, 2004·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·B Ljungberg
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John S LamRobert A Figlin
Sep 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi HirataRajvir Dahiya
May 18, 2021·Frontiers in Oncology·Florent PetitprezSylvie Job
Apr 30, 2011·Archives of Pathology & Laboratory Medicine·George J Netto

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.